LSTA today
$1.28+$0.08 (+6.67%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minBearish
5 minSymmetric Triangle
Daily trend turns up above $1.15
Key levels
Resistance$1.57
Resistance$1.40
Support$1.15
Support$0.96
Latest news & SEC filings
DealLisata Therapeutics Registers 350,498,987 Shares for Selling Holders
SEC FilingLisata Therapeutics, Inc. filed a shelf registration for future offerings (Form S-3)
All LSTA news →About Lisata Therapeutics
Lisata Therapeutics develops experimental medicines for hard-to-treat tumors and other severe illnesses. Its lead candidate, certepetide, aims to switch on a natural transport mechanism so that other cancer drugs given alongside it can reach and build up inside tumors more effectively. The company runs studies of certepetide in pancreatic, bile duct, appendix, colon, and brain cancers, often combined with chemotherapy or immunotherapy. It is based in the United States and conducts research there and in other countries.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Healthcare
LISATA THERAPEUTICS, INC. (LSTA)
What Is the Price Target for LSTA?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is LSTA a Buy or Sell Right Now?
Thesis
- •Revenue growing -83.0% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for LSTA.
Start Free Trial →Is LSTA Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, PEG
Fair Value
$1.27
17
Moat Score
NONE
1/9
Piotroski Score
-44.9
Altman Z-Score
What Is Smart Money Doing with LSTA?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
DISTRIBUTING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →LSTA Growth Story
Revenue YoY
-83.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
20.42%
FCF Growth YoY
17.5%
Revenue Trend
UNKNOWN
Dark Pool Trades for LSTA
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for LSTA, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:59:15 | $1.25 | 1,859 | $$2K | MIDPOINT |
| 19:46:23 | $1.25 | 1,000 | $$1K | BUY |
| 18:25:03 | $1.23 | 1,500 | $$2K | SELL |
| 18:13:01 | $1.25 | 1,700 | $$2K | SELL |
| 17:56:02 | $1.26 | 1,618 | $$2K | SELL |
5 dark pool trades shown · $$10K preview volume
Real-time institutional flow, block trades, and net positioning
What Traders Are Saying About LSTA
1 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for LSTA. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
$LSTA: Thu Nov 12 is noted. No other details were provided.
Join 3,500+ traders discussing LSTA in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for LISATA THERAPEUTICS, INC. (LSTA) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →LSTA — frequently asked questions
What is LSTA stock price today?
LISATA THERAPEUTICS, INC. (LSTA) is at $1.28, up 6.67% (+$0.08) at the Nov 12, 2026 close.
Why is LSTA stock moving today?
Latest LSTA news — Nov 12, 2026: Lisata Therapeutics Registers 350,498,987 Shares for Selling Holders · Nov 12, 2026: Lisata Therapeutics, Inc. filed a shelf registration for future offerings (Form S-3)
What do analysts rate LSTA?
Analyst ratings for LSTA: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did LSTA beat earnings?
LSTA last reported on Aug 6, 2026: EPS -$0.32.
Does LSTA pay a dividend?
LSTA does not currently pay a dividend.
What are LSTA support and resistance levels?
Support: $1.15, $0.96. Resistance: $1.40, $1.57, $1.81.
What are insiders doing with LSTA?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on LSTA?
Nov 12, 2026: Lisata Therapeutics Registers 350,498,987 Shares for Selling Holders · Nov 12, 2026: Lisata Therapeutics, Inc. filed a shelf registration for future offerings (Form S-3)